Back
Protagonist Therapeutics Stock Predictions
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
48
PTGX
Protagonist Therapeutics
Last Price:
$45.78
Seasonality Move:
20.24%
7 Day Trial
ALL ACCESS PASS
$
7
The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Protagonist Therapeutics Stock Forecast
-
Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 51.8% based on the past 8 years of stock performance.
-
Protagonist Therapeutics has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Protagonist Therapeutics Stock Undervalued?The current Protagonist Therapeutics [PTGX] share price is $46.43. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 51.8% based on the past 8 years of stock performance.
Protagonist Therapeutics Stock Rating
Sell
48
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics overpriced?
-
Protagonist Therapeutics has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
60.60
52-Week Low:
27.00
Prediction Charts
Market Cap:
2.9B
Price in USD:
46.43
Volume:
850.6K
Beta:
1.95
Technical Analysis
SMA50:
46.33
SMA100:
42.87
SMA200:
43.09
52-Wk Change:
52.68%
Stock Predictions
-
Is Protagonist Therapeutics stock public?Yes, Protagonist Therapeutics is a publicly traded company.
-
What is the Protagonist Therapeutics stock quote today?The Protagonist Therapeutics stock price is 46.43 USD today.
-
How to buy Protagonist Therapeutics stock online?You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-7 | 41.77 | 43.09 | 43.20 | 41.29 |
| May-8 | 42.60 | 43.92 | 44.37 | 41.60 |
| May-9 | 44.15 | 42.97 | 45.43 | 42.85 |
| May-12 | 43.77 | 45.27 | 45.83 | 43.75 |
| May-13 | 45.23 | 44.27 | 45.23 | 43.27 |
| May-14 | 44.44 | 43.77 | 45.26 | 43.20 |
| May-15 | 44.12 | 44.41 | 44.76 | 43.47 |
| May-16 | 44.35 | 44.49 | 45.20 | 44.11 |
| May-19 | 44.45 | 45.57 | 45.58 | 44.04 |
| May-20 | 45.60 | 46.61 | 46.63 | 44.72 |
| May-21 | 46.02 | 45.82 | 46.80 | 45.05 |
| May-22 | 45.63 | 45.91 | 46.03 | 45.18 |
| May-23 | 45.69 | 45.66 | 45.99 | 45.14 |
| May-27 | 46.42 | 46.43 | 46.51 | 45.28 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.13 per share, a decrease this year of $4.12 per share, and an increase next year of $0.45 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.